Neurofilament Light Chain and Differentiation of Behavioral Variant Frontotemporal Dementia From Psychiatric Disorders: A Systematic Review
All Authors:
Dimitry Davydow, Morgan Brasfield, Christopher Marrow, Adam Staffaroni, Gregory Pantone, Breton Asken
Published in: The Journal of the American Medical Association – Psychiatry
Read more: https://pubmed.ncbi.nlm.nih.gov/40928798/
What’s this study about?
Behavioral variant frontotemporal dementia (bvFTD) is the most common type of frontotemporal dementia and often affects people at a younger age. It can be hard to diagnose because its symptoms—like changes in behavior and personality—can look a lot like common psychiatric disorders. This makes it easy for doctors to confuse the two.
Researchers wanted to see if measuring a protein called neurofilament light chain (NfL) in spinal fluid or blood could help doctors tell the difference between bvFTD and psychiatric disorders more accurately and more quickly.
Key Findings:
Researchers reviewed thousands of studies and found 12 that focused on a protein called neurofilament light chain (NfL), which can be measured in blood and spinal fluid. These studies compared people with bvFTD to those with psychiatric disorders.
NfL levels were much higher in people with bvFTD. Tests using NfL were very good at telling the difference between the two groups, suggesting NfL could be a helpful tool for doctors when diagnosing bvFTD.
Why It Matters:
Measuring NfL could give doctors a faster and more accurate way to tell the difference between bvFTD and psychiatric disorders, which often look alike. This could lead to earlier diagnoses and better care for patients.
Still, more research is needed. Future studies should follow patients as their symptoms begin, measure how severe the symptoms are, and test NfL levels using tools doctors can easily use in clinics. Researchers also need to study how age affects results, set clear cutoffs for diagnosis, and compare NfL levels with changes found in the brain after death.